Results 201 to 210 of about 18,780,434 (409)
AMERICAN ACHIEVEMENTS AND AMERICAN FAILURES IN PUBLIC HEALTH WORK
, 1915 W. T. Sedgwick
openalex +2 more sources
In Vitro Modeling of Natural Killer Cell Cytotoxicity to Inform Personalized ALS Therapeutics
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Natural killer (NK) cells might contribute to motor neuron death in amyotrophic lateral sclerosis (ALS) through direct cytotoxicity, a process that could be inhibited with the FDA‐approved JAK/STAT pathway inhibitor, tofacitinib. This study aimed to verify that tofacitinib can suppress NK cell cytotoxicity, investigate if immune cell
Benjamin J. Murdock +8 more
wiley +1 more source
PUBLICITY AND THE PUBLIC HEALTH [PDF]
American Journal of Public Health, 1914 openaire +3 more sources
THE NATIONAL HOUSING ASSOCIATION AND ITS RELATION TO PUBLIC HEALTH.
, 1911 Lawrence Veiller
openalex +2 more sources
Real‐World Comparison of High‐Efficacy Versus Non‐High‐Efficacy Therapies in Multiple Sclerosis
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective The choice of the first disease modifying treatment (DMT) in multiple sclerosis (MS) is a topic of great interest, and whether high‐efficacy DMTs should be the first choice remains debated. We compared treatment outcomes (no evidence of disease activity [NEDA] and its components) between treatment‐naïve relapsing–remitting MS (RRMS ...
Sarmad Al‐Araji +9 more
wiley +1 more source
Digital technologies in the public-health response to COVID-19
Nature Network Boston, 2020 Jobie Budd +16 more
semanticscholar +1 more source
The dawn of digital public health in Europe: Implications for public health policy and practice
The Lancet Regional Health - Europe, 2022 B. Wong +6 more
semanticscholar +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the long‐term impact of early intensive treatment (EIT) versus escalation (ESC) strategies using high‐efficacy disease‐modifying therapies (HE‐DMTs) on disability progression in relapsing multiple sclerosis (RMS). Methods This observational study included 4878 RMS patients from the Italian Multiple Sclerosis Register ...
Pietro Iaffaldano +47 more
wiley +1 more source
Public Health Medicine, Public Health Practice, and Public Health Systems [PDF]
Canadian Journal of Public Health, 2013 openaire +3 more sources